Canada markets closed

Y-mAbs Therapeutics, Inc. (YMAB)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
12.10+0.09 (+0.75%)
At close: 04:00PM EDT
12.10 0.00 (0.00%)
After hours: 04:20PM EDT
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Cash flows from operating activities
Net Income
-21,666
-21,427
-95,568
-55,275
-119,337
-
Depreciation & amortization
712
735
839
782
396
-
Stock based compensation
12,995
14,453
25,602
19,334
16,135
-
Change in working capital
-9,315
-19,734
-10,371
-7,284
3,444
-
Accounts receivable
-1,886
-9,923
-4,819
-7,712
0
-
Inventory
497
1,637
-1,190
-5,512
0
-
Accounts Payable
-1,909
-6,856
-919
4,180
852
-
Other working capital
-17,585
-27,232
-75,921
-103,523
-91,406
-
Other non-cash items
-
-
-
-62,010
8,707
-
Net cash provided by operating activites
-17,585
-27,232
-75,921
-102,556
-91,231
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-
-967
-175
-1,965
Other investing activites
-
-
-
62,010
-2,610
-
Net cash used for investing activites
0
0
0
61,043
-2,785
-
Cash flows from financing activities
Common stock issued
-
-
0
107,725
0
134,704
Net cash used privided by (used for) financing activities
688
100
84
108,314
2,004
-
Net change in cash
-16,880
-27,125
-75,802
66,930
-92,502
-
Cash at beginning of period
92,629
105,762
181,564
114,634
207,136
-
Cash at end of period
75,732
78,637
105,762
181,564
114,634
-
Free Cash Flow
Operating Cash Flow
-17,585
-27,232
-75,921
-102,556
-91,231
-
Capital Expenditure
-
-
-
-967
-175
-1,965
Free Cash Flow
-17,585
-27,232
-75,921
-103,523
-91,406
-